Midway through trading Wednesday, the Dow traded up 0.32% to 32,930.37while the NASDAQ fell 1.08% to 13,325.62. The S&P also fell, dropping 0.39% to 3,947.09.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,549,550 cases with around 536,920 deaths. Brazil reported over 11,603,530 COVID-19 cases with 282,120 deaths, while India confirmed a total of at least 11,438,730 cases and 159,040 deaths. In total, there were at least 120,791,360 cases of COVID-19 worldwide with more than 2,672,480 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Industrials shares rose 0.9% on Wednesday. Meanwhile, top gainers in the sector included Willis Lease Finance Corporation WLFC 27.38%, up 25%, and Navios Maritime Holdings Inc. NM 27.25%, up 17%.
In trading on Wednesday, information technology shares fell 1.2%.
Top Headline
Cintas Corporation CTAS 2.59% reported better-than-expected results for its third quarter.
Cintas posted quarterly earnings of $2.37 per share, beating analysts’ estimates of $2.21 per share. The company’s quarterly sales came in at $1.78 billion, exceeding expectations of $1.75 billion.
Cintas said it expects Q4 EPS of $2.20-$2.40 versus analysts’ estimates of $2.18. The company projects sales of $1.8 billion-$1.83 billion.
Equities Trading UP
Immatics N.V. IMTX 27.73% shares shot up 30% to $15.10 after the company announced a clinical data update from the dose escalation cohorts of the company's ongoing Phase 1 trials for its engineered Adoptive Cell Therapy.
Shares of FSD Pharma Inc. HUGE 15.46% got a boost, shooting 13% to $2.33 as the company entered into a license agreement to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats..
Mistras Group, Inc. MG 14.59% shares were also up, gaining 13% to $11.80 after the company reported-better-than-expected Q4 results.
Check out these big movers of the day
Equities Trading DOWN
IMV Inc. IMV 18.72% shares tumbled 17% to $3.24 after the company reported a wider FY20 loss.
Shares of Rubius Therapeutics, Inc. RUBY 17.95% were down 18% to $26.32 after the company priced its 6.9 million share common stock at $29 per share. Rubius Therapeutics recently reported initial data from its ongoing Phase 1/2 trial of RTX-240 in patients with advanced solid tumors.
South Jersey Industries, Inc. SJI 16.39% was down, falling 17% to $23.08 after the company announced a $225 million common stock and equity units offering.
Commodities
In commodity news, oil traded down 0.9% to $64.22, while gold traded down 0.3% to $1,725.20.
Silver traded down 0.1% Wednesday to $25.97 while copper rose 1.1% to $4.1180.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 fell 0.45%, the Spanish Ibex Index fell 0.69% and the German DAX 30 gained 0.18%. Meanwhile, the French CAC 40 rose 0.06%, London’s FTSE 100 fell 0.51% and Italy’s FTSE MIB rose 0.04%.
Demand for new passenger cars in the European Union dipped 19.3% annually to 771,486 units in February.
Economics
Housing starts dropped 10.3% to an annualized rate of 1.421 million in February, while building permits dipped 10.8% to an annual rate of 1.682 million in February.
US crude oil inventories increased 2.396 million barrels fir the week ended March 12, following a 13.798-million rise in the previous week, the Energy Information Administration said.
The Federal Reserve will announce its policy decision at 2:00 p.m. ET.
The Fed Chairman Jerome Powell will hold a press conference at 2:30 p.m. ET.
Benzinga does not provide investment advice. All rights reserved.
Recommended content
Editors’ Picks
EUR/USD stays below 1.0800 after upbeat US data
EUR/USD stays under bearish pressure and trades slightly below 1.0800 in the American session on Thursday. The data from the US showed that the real GDP growth for the fourth quarter got revised higher to 3.4% from 3.2%, supporting the USD and weighing on the pair.
GBP/USD stays in daily range above 1.2600
GBP/USD fluctuates in a narrow channel above 1.2600 on Thursday. The better-than-expected Initial Jobless Claims data from the US and the upward revision to the Q4 GDP growth helps the USD stay resilient against its rivals and limits the pair's upside.
Gold clings to strong daily gains above $2,200
Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Friday. The benchmark 10-year US Treasury bond yield stays above 4.2% after upbeat US data and makes it difficult for XAU/USD to preserve its bullish momentum.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
Portfolio rebalancing and reflation trades emerge into Q2
Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.